These findings highlight the potential of MnSOD and its regulatory pathways as therapeutic targets for obesity-related metabolic disorders, though tissue-specific strategies will be crucial moving forward. Here, SOD2 is linked to obesity due to melanocortin 4 receptor deficiency.